Insulet Corporation (PODD)

166.19 +2.02 (+1.23%) At close: 04:00PM EDT

Insulet Corporation

100 Nagog Park
Acton, MA 01720
United States
978 600 7000
https://www.insulet.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 3,000

Key executives

Name	Title	Pay	Exercised	Year born
Dr. James R. Hollingshead Ph.D.	President, CEO & Director	2.88M	N/A	1963
Mr. Mark Field	Senior VP & CTO	954.14k	N/A	1971
Mr. John Wodick Kapples	Senior VP & General Counsel	1.02M	N/A	1960
Ms. Shacey Petrovic	Director & Advisor	28.57k	N/A	1973
Mr. Eric Benjamin	Executive VP, Chief Product & Customer Experience Officer	1.14M	N/A	1983
Mr. Prem Singh	Senior Vice President of Global Operations	N/A	N/A	1977
Ms. Laetitia Cousin	Senior VP of Regulatory Affairs, Quality Assurance & Compliance	N/A	N/A	1976
Angela Geryak Wiczek	Senior Director of Corporate Communications	N/A	N/A	N/A
Mr. Philip Hildale	Senior Vice President of Sales & Customer Care	N/A	N/A	N/A
Mr. Andrew Isaacson	Senior VP of Strategy & Corporate Development	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Corporate governance

Insulet Corporation’s ISS governance QualityScore as of 1 April 2024 is 9. The pillar scores are Audit: 6; Board: 7; Shareholder rights: 10; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.